Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 45 Life Science Angel Investors in United Kingdom in January 2026

Last updated: Jan 2026 A list of 45 angel investors that invest in Life science startups based in United kingdom. We rank investors based on the number of investments they made in Life science companies from United kingdom. We update this investor list every month.

Top 45 Life Science Angel Investors in United Kingdom in January 2026

Investor	Life Science United Kingdom investments
Jonathan Milner	9
Nadav Rosenberg	4
Stefano Bernardi	3
Jeff Dean	3
Darrin Disley	2
Mati Staniszewski	2
Aidan Gomez	2
Bradley Horowitz	2
Damien Lane	2
Nicholas Edwards	2
Mark Evans	2
Ed Parkinson	2
Jan Hruska	2
Jude Gomila	2
Robert Kopple	2
Ian Hogarth	2
Johnathan Matlock	1
David Lucas	1
Jim Warwick	1
Simon Galbraith	1
Nadav Ben-Chanoch	1
Duncan Grierson	1
Michelle Tempest	1
Mark Gillespie	1
Edward Lando	1
Andrew Fisher	1
Tim Davis	1
Sophia Bendz	1
Matt Clifford	1
Keith Willey	1
Will Martin	1
Rick Bernstein	1
Naheed Kurji	1
Will Brooks	1
Michail Eleftheriou	1
John Anthony Knight	1
Maximilien Levesque	1
Irina Elena Haivas	1
Sharaf Yamani	1
David Evans	1
Huw Bishop	1
Jon Oringer	1
Sami Mikati	1
Jon Oringer	1
Vishal Gulati	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Spain

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Exciting Instruments — We're on a mission to simplify single-molecule fluorescence spectroscopy and make it accessible to all. Find out more about our company, our products and what makes us different.

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Investment focus

Biotechnology, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United Kingdom, France, Israel

Portfolio highlights

Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
thymia — Making mental health as objectively measurable as physical health.
Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Investment focus

Biotechnology, Software, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, Italy, France

Portfolio highlights

Freatic — Building the monetization layer for your alpha
CaSRevolution — A novel disease-modifying approach against neurodegeneration
Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Investment focus

Artificial Intelligence, Information Technology, Software
Seed, Series A, Pre-Seed
United States, United Kingdom, Japan

Portfolio highlights

Sophont — Multimodal foundation models for healthcare
Onepot.ai — Onepot.ai offers automated synthesis of small molecules from basic building blocks using a unified, end-to-end process. It generates around fifty distinct compounds in a single workflow, eliminating the need for bespoke methods for each target. The platform employs modular couplings, deprotection, and streamlined purification steps to rapidlyassemble structurally diverse molecules. It supports chemistries that produce both sp²- and sp³-rich frameworks, enabling applications across pharmaceutical, materials, and probe development. By leveraging a catch-and-release purification protocol and iterative building-block assembly, Onepot.ai enables efficient production of complex small-molecule libraries.
Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Investment focus

Biotechnology, Health Care, Big Data
Seed, Series A, Funding Round
United Kingdom

Portfolio highlights

bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.

Mati Staniszewski is the Co-Founder of ElevenLabs.

Investment focus

Software, Information Technology, Artificial Intelligence
Pre-Seed
United States

Portfolio highlights

Oboe — Oboe is an AI-powered educational platform that offers resources for learning.
VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
SalesPatriot — SalesPatriot serves as an advanced back-office operating system tailored for companies within the defense sector.

Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Pre-Seed, Series A
United States, United Kingdom, Canada

Portfolio highlights

DatologyAI — DatologyAI optimize training efficiency, maximize performance and reduce compute costs with expert curation.
Extropic AI — The next era of computing isn't dead. It's alive. More coming soon.
Borderless AI — Borderless AI is an Employer of Record (EOR) & PEO platform simplifying global payroll management & team hiring to empower your growth worldwide. Book a demo now!

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
United States, United Kingdom, Germany

Portfolio highlights

Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
Opal — Making it better at capturing incredible low-light video. Even in dimly lit room, you’ll get a level of detail and color that wasn’t possible before.The Opal C1 comes with MicMesh™, an array of beamforming microphones that find and focus on the sound of your voice. And with intelligent noise cancellation, every ding, drop and dog bark is filteredout to get an audio experience that clearly speaks for itself.
Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Investment focus

Software, SaaS, Health Care
Seed, Pre-Seed, Series A
United Kingdom, United States, Ireland

Portfolio highlights

Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.

Investment focus

Software, E-Commerce, Health Care
Series A, Seed, Series C
United Kingdom, United States, The Netherlands

Portfolio highlights

8fit — Get personalized workouts, custom meal plans, and nutrition guidance, right in the palm of your hand. Prioritize progress over perfection with the 8fit app!
Ufonia — Ufonia combines AI and clinical evidence to automate routine clinical conversations, making care more convenient, reliable and consistent for patients.
Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.

Ed Parkinson

Investment focus

Software, Health Care, Life Science
Seed
United Kingdom

Portfolio highlights

Antiverse — Designing biologics for 100 challenging targets

Jan Hruska

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Jude Gomila is currently CEO and Founder of the startup Golden.

Investment focus

Software, Biotechnology, Information Technology
Seed, Pre-Seed, Angel
United States, United Kingdom, Canada

Portfolio highlights

Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!

Robert Kopple

Investment focus

FinTech, Finance, Life Science
Funding Round, Convertible Note
United States, United Kingdom

Portfolio highlights

Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Investment focus

Software, E-Commerce, Internet
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
Fabric — One home for your digital world. Your second brain. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files in one calm, minimal app. No organizing required. Never forget anything again.

Johnathan Matlock is Co-Founder Science Angel Syndicate.

Investment focus

Biotechnology, Medical, Health Care
Seed, Pre-Seed, Funding Round
United Kingdom

Portfolio highlights

OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.

David Lucas

Investment focus

Software, Life Science, Biotechnology
Seed
United Kingdom

Portfolio highlights

Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.

Jim started work at Analysys Limited, a Cambridge-based telecommunications consultancy, heading up its IT, software and web development initiatives. Jim then joined Abcam as a Technical Director, and took over the operational management of the UK office as Managing Director in June 2004, working on both cost saving and efficiency improvementprojects. In 2009, Jim became Chief Operating Officer, with the responsibility for overseeing the operational strategy of the Group. Jim is a Director of Chesterton Community College, Chesterton Sports Centre Limited and Cambridge Nutraceuticals Limited. He has also taken up a non-executive position at Quartix Holdings Plc. Jim had over 15 years’ experience in developing and implementing IT systems and strategy before moving into a broader operational management role within Abcam.Here his skills have been particularly focused on developing a scalable operating model for Abcam which, supported by IT systems, has underpinned Abcam’s rapid growth over the past decade.

Investment focus

Life Science, Biotechnology
Seed
United Kingdom

Portfolio highlights

Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team

Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.

Investment focus

Software, Health Care, Life Science
Pre-Seed, Funding Round
Croatia, United Kingdom

Portfolio highlights

BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
SysKit — Syskit Point is your go-to platform for governing the entire M365 lifecycle. Reporting, auditing, and governance - simplified. Start your 21-day free trial.

Nadav Ben-Chanoch

Investment focus

Software, Information Technology, Health Care
Seed, Pre-Seed, Funding Round
United States, United Kingdom, France

Portfolio highlights

Blobr — Get your branded developer portal to launch and grow adoption of your API products.
Tavrn — Tavrn provides state of the art, AI-powered demand letters and medical chronologies for attorneys.
Dotfile — Dotfile is the Compliance Orchestration Platform for Fintechs. Streamline KYC & KYB and scale AML/CFT due diligences over +200 countries.

Duncan Grierson

Investment focus

Water, Medical, CleanTech
Seed, Series A
United Kingdom

Portfolio highlights

Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.

Michelle Tempest

Investment focus

Health Care, Cannabis, Life Science
Seed, Series A
United Kingdom

Portfolio highlights

Daye — Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana).
Medwise.ai — Medwise.ai is the Google for doctors.

Mark Gillespie, born in Solihull, August 30th 1981, is a prominent music industry executive and entrepreneur, currently serving as the CEO of Three Six Zero, a global entertainment management company. With a career spanning over two decades, Gillespie has been instrumental in managing and guiding the careers of high-profile artists, producers,and creatives, including internationally acclaimed stars like Calvin Harris, Frank Ocean and Kid Cudi. Beyond his role at Three Six Zero, he owns the record label, Three Six Zero Recordings, Three Six Zero Music Publishing, and an interest in UK film distribution company, True Brit Entertainment. He is also credited as an executive producer on the movies Vox Lux (starring Natalie Portman and Jude Law) The Brutalist (starring Adrien Brody, Joe Alwyn and Felicity Jones) and Marching Powder (starring Danny Dyer).In 2023 he purchased the legendary SARM Recording Studios in London.Additionally Mark is an active investor in the technology space and holds a portfolio of investments in businesses such as Openai, SpaceX, Doordash, Figma, Stripe, OpenSea Gemini and Lyft. As well as being an LP at Andreessen Horowitz.He serves on the entertainment board of the charity Children In Conflict. His forward thinking vision and innovative approach to talent management have positioned Three Six Zero as a leading entity in the industry, known for representing leading talent in their respective fields of music, film, television and sports.

Investment focus

Music, Internet, Video
Funding Round, Seed, Series B
United States, United Kingdom, India

Portfolio highlights

Bkstg — Bkstg was founded by tech and music entrepreneurs to reinvent the way artists and fans connect by creating a new form of direct relationship that’s never existed before.
Hyperice — HyperIce is a recovery and movement enhancement technology company specializing in vibration, percussion, and thermal technology. Its technology is used by the athletes in professional and collegiate training rooms and fitness facilities globally.The company is driven by a mission to provide everyone with the innovative technology in acceleratingrecovery time, preventing injury, and enhancing the body’s ability to move efficiently. HyperIce was founded in 2010 by Anthony Katz.
Biosceptre — A Promise Beyond Cancer Envisioning the future of targeted therapeutics Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Investment focus

Software, Health Care, Information Technology
Seed, Pre-Seed, Funding Round
United States, France, United Kingdom

Portfolio highlights

Volta — Our mission is to empower brands, wholesalers, and distributors with the tools and support to thrive in today's digital economy.
Swish Robotics — Embodied Intelligence for the Home
Workflow — A minimalist collaboration platform for creative teams. Manage tasks, get AI reviews, and share work, all in one place.

As an Executive Vice President at Wesley Clover, Andrew currently manages a portfolio of ICT and Digital Media companies globally. In addition he also acts as a business prime for the Wesley Clover affiliate program.Andrew connects teams of new graduates with tier one Network Operator, Service Provider and Communications EquipmentManufactures globally. These partnerships provide invaluable customer insight and a route to market for each of the Affiliates. Through these partnerships, each party realizes time to revenue, time to market and engine for innovation advantage.Andrew serves on the Board of Directors for March Entertainment, Benbria and Teldio Corporations. He is also a member of the Advisory board for the Canadian Digital Media Network and the Canadian Department of Foreign Affairs and International Trade Information and Communications Technologies.Andrew is an honors graduate from the University of British Columbia, with an academic background in Computer Science, Engineering and Economics.

Investment focus

Medical, Life Science, Biotechnology
Series A
United Kingdom

Portfolio highlights

MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.

Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries. He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
United States, United Kingdom, Germany

Portfolio highlights

Bryn Pharma — Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
MycoMedica Life Sciences, PBC — Psychedelic Medicines

Sophia Bendz - Partner @ Cherry Ventures

Investment focus

Health Care, Software, Apps
Seed, Pre-Seed, Funding Round
Sweden, United Kingdom, United States

Portfolio highlights

mayk — Mayk sounds. Mayk music. Mayk noise. Mayk it... In an app.
Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Investment focus

Software, FinTech, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, India, United States

Portfolio highlights

Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Bondaval — Bondaval secures receivables for the world's best credit teams, so they can extend more credit, win more business and get better financing terms.
Koos — KOOS is a simple legal and technological solution for motivating and rewarding your community. Boost your growth by sharing success.

Keith is an associate professor of strategic and international management and entrepreneurship at London Business School as well as a senior lecturer at University College London. He also holds various non-executive directorships and advisory roles. His career has spanned academia, consulting, investing and hands-on operational roles withinindustry and the venture capital world.

Investment focus

Software, Media and Entertainment, Gaming
Seed, Angel, Pre-Seed
United Kingdom, Spain, Portugal

Portfolio highlights

Rise Art — Discover, own and collect contemporary art from exciting artists from around the world. Explore our online art gallery with artwork for sale that has been expertly vetted by our curators. Buy or rent art online with confidence with free art advisory.
NumberEight — Empower your targeting and curation with NumberEight's smart, privacy-first data. Designed for publishers, ad platforms and agencies to drive performance across podcasting, mobile and CTV.
Urban Roosters — Urban Roosters is the original rap streaming platform. The RAP unlike other types of music, has always had a competitive spirit. What they do in Urban Roosters is to bring this competitions to internet, letting our users compete with rappers all over the world, trespassing the physical as an entertainment platform for the rap lovers.

Will Martin - Founder and Director @ Portfolio Ventures

Investment focus

Financial Services, Software, FinTech
Seed, Funding Round, Series A
United Kingdom, Japan, United States

Portfolio highlights

Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Loadsure — Loadsure is a spot freight cargo insurance company.
Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.

Rick Bernstein is the Chief Commercial Officer for MedNet responsible for the development of the commercial infrastructure and strategy for MedNet, a healthcare technology company specializing in eClinical solutions for the global life sciences industry. Rick is currently leading the development of an optimized sales, business development, anddistribution strategy to drive aggressive growth across key market segments, including CROs and pharmaceutical, medical device and biotechnology sponsors.

Investment focus

Biotechnology, AgTech, Farming
Seed, Pre-Seed
United Kingdom, The Netherlands

Portfolio highlights

Farmless — A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks.
Phytoform Labs — Phytoform Labs is improving crops to make agriculture more sustainable and nutritious

Naheed Kurji is the President and CEO of Cyclica, a Toronto-based biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica provides the pharmaceutical industry with an integrated, holistic, and end-to-end enabling platform that enhances how scientists design, screen,and personalize medicines for patients, and has recently been named by Deep Knowledge Analytics as one of the top 20 AI in Pharma companies globally. Naheed is passionate about how people interact with technology to make more informed and faster decisions, and is dedicated to advancing the responsible application of AI to healthcare problems. At Cyclica, he focuses on strategy and corporate development activities to affect change in the pharmaceutical industry, and strives to foster an environment where his team can solve the biggest challenges in human health through groundbreaking innovation. Naheed is a co-founder of The Alliance for Artificial Intelligence in Healthcare (AAIH), of which Naheed is 1 of 4 appointed Executive Officers. Naheed is an experienced professional specialized in strategic planning, corporate finance and entrepreneurship, having received an MBA from the University of Toronto, Rotman School of Management, and a Certificate from MIT on Artificial Intelligence and the Implication on Business Strategy. He has been featured in the Globe and Mail, CBC, Forbes, Vanity Fair, StartUp Health Magazine, WuXi Insider Perspective, and VentureBeat. Naheed is also a guest lecturer at various universities globally on the topic of entrepreneurship and AI in medicine.

Investment focus

Life Science, Biotechnology
Seed
United Kingdom

Portfolio highlights

CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics

Will Brooks - Founder & Director @ Portfolio Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.

Michail Eleftheriou

Investment focus

Software, Life Science, Biotechnology
Seed
United Kingdom

Portfolio highlights

Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
2Go Mobile Now —

John Anthony Knight

Investment focus

Software, Life Science, Biotechnology
Seed
United Kingdom

Portfolio highlights

Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.

Maximilien Levesque - CEO and co-founder @ AQEMIA

Investment focus

Life Science, Biotechnology
Seed
United Kingdom

Portfolio highlights

CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics

Irina Haivas is a Principal. Based in London, she works on sourcing and due diligence of global investment opportunities.Irina focuses on businesses that use advanced technologies such as machine intelligence or robotics and automation, to transform large industries. She also focuses on the intersection of science and technology, including nextgeneration biology, as well as on companies in healthcare.Before joining Atomico, Irina was a growth and PE investor at GHO Capital Partners, where she invested, among others, in enterprise software and AI/ML businesses and focused on the intersection of science, healthcare and technology. Before that, Irina was part of the leadership team of Bain & Co. in Europe and the U.S., where she worked directly both with private equity firms on investment diligence, as well as with corporates on Innovation and Product, Go-to-Market, BD and acquisitions, and organisation scale-up. While at Bain she seconded in an operational role at Medtronic, one of the world’s largest medical engineering companies.Irina is a former surgeon, having studied medicine at Freiburg University in Germany and Iasi Medical University in Romania. She was a surgical fellow at Harvard Medical School before completing an MSc (Dist) in International Health Policy at London School of Economics.Irina speaks Romanian, English, advanced German, and conversational French.

Investment focus

Health Care, Artificial Intelligence, Biotechnology
Series A, Series B, Seed
United Kingdom, Estonia, Germany

Portfolio highlights

Daye — Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana).
Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
LabGenius — Finding the next generation of drugs with machine learning, synthetic biology and laboratory automation

Sharaf Yamani - Managing Director @ Windlesham Advisors

Investment focus

Biotechnology, Software, Life Science
Seed
India, United Kingdom

Portfolio highlights

CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.

Principal at Apax Digital.

Investment focus

Rental, Medical, Software
Series A, Series D, Series E
Israel, United Kingdom

Portfolio highlights

Guesty — Guesty simplifies the way property managers work.
MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.

Huw Bishop is an individual investor.

Investment focus

EdTech, Training, E-Learning
Angel
United Kingdom

Portfolio highlights

clear_pixel VR — Build real-world laboratory skills in virtual reality. Our VR simulations teach micropipetting, mouse injections, and molecular neuroscience. Scalable, ethical, and cost-effective.

Jon Oringer is the founder and chairman of Shutterstock.

Investment focus

Software, Information Technology, Health Care
Seed, Pre-Seed, Funding Round
United States, France, United Kingdom

Portfolio highlights

BRXS — Real Estate investing
Mietz — The first fully automized all-in-one renting platform for tenants and landlords.
OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.

Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.

Investment focus

Biotechnology, Software, Life Science
Seed
India, United Kingdom

Portfolio highlights

CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.

Jon Oringer is the founder and chairman of Shutterstock.

Investment focus

Software, Information Technology, E-Commerce
Seed, Pre-Seed, Funding Round
United States, United Kingdom, France

Portfolio highlights

Jome — On our platform, you can search for and tour thousands of new construction homes and communities near you. Our new home experts are ready to guide you through the entire home-buying process and will help you turn your dream home into a reality
Unsloth AI — Open source fine-tuning & reinforcment learning (RL) for gpt-oss, Llama 4, DeepSeek-R1, Gemma, and Qwen3 LLMs! Beginner friendly.
OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.

Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe's leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, whichsupports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis.

Investment focus

Biotechnology, Biopharma, Life Science
Seed, Series A, Series B
United Kingdom, Hungary

Portfolio highlights

Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
evonetix — evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniqueswe are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
Turbine — Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.

Investors by industry

Community

Artificial intelligence